Retatrutide (LY3437943)

Price range: $53.00 through $210.00

Retatrutide (LY3437943) is an investigational triple-hormone agonist developed by Eli Lilly that activates GLP-1, GIP, and glucagon receptors. Designed as a once-weekly injection, it drives significant weight loss (up to 24-28% of body weight in trials) by curbing appetite, optimizing metabolism, and actively increasing energy expenditure